COTERRA ENERGY INC (CTRA) Stock Fundamental Analysis

NYSE:CTRA • US1270971039

31.37 USD
+0.59 (+1.92%)
At close: Feb 13, 2026
31.38 USD
+0.01 (+0.03%)
After Hours: 2/13/2026, 8:04:00 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership News
Fundamental Rating

6

Taking everything into account, CTRA scores 6 out of 10 in our fundamental rating. CTRA was compared to 206 industry peers in the Oil, Gas & Consumable Fuels industry. CTRA scores excellent on profitability, but there are some minor concerns on its financial health. CTRA is showing excellent growth while it is valued at reasonable prices. Keep and eye on this one! With these ratings, CTRA could be worth investigating further for growth investing!.


Dividend Valuation Growth Profitability Health

7

1. Profitability

1.1 Basic Checks

  • In the past year CTRA was profitable.
  • CTRA had a positive operating cash flow in the past year.
  • Each year in the past 5 years CTRA has been profitable.
  • Each year in the past 5 years CTRA had a positive operating cash flow.
CTRA Yearly Net Income VS EBIT VS OCF VS FCFCTRA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B 2B 3B 4B 5B

1.2 Ratios

  • CTRA has a Return On Assets of 6.86%. This is in the better half of the industry: CTRA outperforms 76.70% of its industry peers.
  • CTRA's Return On Equity of 11.18% is fine compared to the rest of the industry. CTRA outperforms 66.50% of its industry peers.
  • CTRA has a Return On Invested Capital of 7.86%. This is in the better half of the industry: CTRA outperforms 73.79% of its industry peers.
  • The Average Return On Invested Capital over the past 3 years for CTRA is significantly below the industry average of 21.98%.
  • The 3 year average ROIC (12.27%) for CTRA is well above the current ROIC(7.86%). The reason for the recent decline needs to be investigated.
Industry RankSector Rank
ROA 6.86%
ROE 11.18%
ROIC 7.86%
ROA(3y)11.08%
ROA(5y)8.7%
ROE(3y)17.66%
ROE(5y)14.37%
ROIC(3y)12.27%
ROIC(5y)9.93%
CTRA Yearly ROA, ROE, ROICCTRA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 20 30

1.3 Margins

  • CTRA's Profit Margin of 23.25% is amongst the best of the industry. CTRA outperforms 80.58% of its industry peers.
  • CTRA's Profit Margin has declined in the last couple of years.
  • CTRA's Operating Margin of 31.31% is fine compared to the rest of the industry. CTRA outperforms 77.18% of its industry peers.
  • CTRA's Operating Margin has declined in the last couple of years.
  • Looking at the Gross Margin, with a value of 82.81%, CTRA belongs to the top of the industry, outperforming 92.23% of the companies in the same industry.
  • In the last couple of years the Gross Margin of CTRA has grown nicely.
Industry RankSector Rank
OM 31.31%
PM (TTM) 23.25%
GM 82.81%
OM growth 3Y-19.39%
OM growth 5Y-9.76%
PM growth 3Y-15.14%
PM growth 5Y-9.04%
GM growth 3Y1.7%
GM growth 5Y3.22%
CTRA Yearly Profit, Operating, Gross MarginsCTRA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 60 80

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

5

2. Health

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), CTRA is creating some value.
  • The number of shares outstanding for CTRA has been reduced compared to 1 year ago.
  • CTRA has more shares outstanding than it did 5 years ago.
  • CTRA has a worse debt/assets ratio than last year.
CTRA Yearly Shares OutstandingCTRA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M
CTRA Yearly Total Debt VS Total AssetsCTRA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B 20B

2.2 Solvency

  • An Altman-Z score of 2.51 indicates that CTRA is not a great score, but indicates only limited risk for bankruptcy at the moment.
  • CTRA has a better Altman-Z score (2.51) than 74.76% of its industry peers.
  • The Debt to FCF ratio of CTRA is 2.71, which is a good value as it means it would take CTRA, 2.71 years of fcf income to pay off all of its debts.
  • Looking at the Debt to FCF ratio, with a value of 2.71, CTRA is in the better half of the industry, outperforming 78.16% of the companies in the same industry.
  • CTRA has a Debt/Equity ratio of 0.25. This is a healthy value indicating a solid balance between debt and equity.
  • CTRA has a better Debt to Equity ratio (0.25) than 67.96% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.25
Debt/FCF 2.71
Altman-Z 2.51
ROIC/WACC0.98
WACC8.05%
CTRA Yearly LT Debt VS Equity VS FCFCTRA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B 10B

2.3 Liquidity

  • A Current Ratio of 1.02 indicates that CTRA should not have too much problems paying its short term obligations.
  • With a Current ratio value of 1.02, CTRA perfoms like the industry average, outperforming 44.17% of the companies in the same industry.
  • CTRA has a Quick Ratio of 1.02. This is a bad value and indicates that CTRA is not financially healthy enough and could expect problems in meeting its short term obligations.
  • Looking at the Quick ratio, with a value of 0.98, CTRA is in line with its industry, outperforming 50.00% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.02
Quick Ratio 0.98
CTRA Yearly Current Assets VS Current LiabilitesCTRA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

8

3. Growth

3.1 Past

  • The Earnings Per Share has grown by an impressive 26.74% over the past year.
  • Measured over the past 5 years, CTRA shows a small growth in Earnings Per Share. The EPS has been growing by 0.12% on average per year.
  • CTRA shows a strong growth in Revenue. In the last year, the Revenue has grown by 25.13%.
  • Measured over the past years, CTRA shows a very strong growth in Revenue. The Revenue has been growing by 21.44% on average per year.
EPS 1Y (TTM)26.74%
EPS 3Y-5.3%
EPS 5Y0.12%
EPS Q2Q%28.12%
Revenue 1Y (TTM)25.13%
Revenue growth 3Y16.53%
Revenue growth 5Y21.44%
Sales Q2Q%33.7%

3.2 Future

  • Based on estimates for the next years, CTRA will show a quite strong growth in Earnings Per Share. The EPS will grow by 15.83% on average per year.
  • The Revenue is expected to grow by 11.96% on average over the next years. This is quite good.
EPS Next Y31.29%
EPS Next 2Y14.82%
EPS Next 3Y18.81%
EPS Next 5Y15.83%
Revenue Next Year37.46%
Revenue Next 2Y18.81%
Revenue Next 3Y14.98%
Revenue Next 5Y11.96%

3.3 Evolution

  • The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
  • The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
CTRA Yearly Revenue VS EstimatesCTRA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2029 2030 2B 4B 6B 8B 10B
CTRA Yearly EPS VS EstimatesCTRA Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 1 2 3 4

More info and screens

Find the best growth stocksShow best growing peers

6

4. Valuation

4.1 Price/Earnings Ratio

  • Based on the Price/Earnings ratio of 14.39, the valuation of CTRA can be described as correct.
  • Based on the Price/Earnings ratio, CTRA is valued a bit cheaper than the industry average as 64.08% of the companies are valued more expensively.
  • The average S&P500 Price/Earnings ratio is at 27.97. CTRA is valued slightly cheaper when compared to this.
  • CTRA is valuated correctly with a Price/Forward Earnings ratio of 14.08.
  • CTRA's Price/Forward Earnings ratio is a bit cheaper when compared to the industry. CTRA is cheaper than 64.08% of the companies in the same industry.
  • CTRA's Price/Forward Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 27.96.
Industry RankSector Rank
PE 14.39
Fwd PE 14.08
CTRA Price Earnings VS Forward Price EarningsCTRA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

  • CTRA's Enterprise Value to EBITDA ratio is a bit cheaper when compared to the industry. CTRA is cheaper than 70.87% of the companies in the same industry.
  • Based on the Price/Free Cash Flow ratio, CTRA is valued a bit cheaper than the industry average as 64.08% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 16.49
EV/EBITDA 6.21
CTRA Per share dataCTRA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15

4.3 Compensation for Growth

  • CTRA's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • The decent profitability rating of CTRA may justify a higher PE ratio.
  • A more expensive valuation may be justified as CTRA's earnings are expected to grow with 18.81% in the coming years.
PEG (NY)0.46
PEG (5Y)121.16
EPS Next 2Y14.82%
EPS Next 3Y18.81%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

5

5. Dividend

5.1 Amount

  • CTRA has a Yearly Dividend Yield of 2.90%. Purely for dividend investing, there may be better candidates out there.
  • Compared to an average industry Dividend Yield of 3.63, CTRA has a dividend in line with its industry peers.
  • Compared to an average S&P500 Dividend Yield of 1.79, CTRA pays a better dividend.
Industry RankSector Rank
Dividend Yield 2.9%

5.2 History

  • On average, the dividend of CTRA grows each year by 18.85%, which is quite nice.
  • CTRA has paid a dividend for at least 10 years, which is a reliable track record.
Dividend Growth(5Y)18.85%
Div Incr Years0
Div Non Decr Years0
CTRA Yearly Dividends per shareCTRA Yearly Dividends per shareYearly Dividends per share 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.5 1 1.5 2

5.3 Sustainability

  • CTRA pays out 40.64% of its income as dividend. This is a bit on the high side, but may be sustainable.
  • CTRA's earnings are growing slower than its dividend. This means the dividend growth is not sustainable.
DP40.64%
EPS Next 2Y14.82%
EPS Next 3Y18.81%
CTRA Yearly Income VS Free CF VS DividendCTRA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B 2B 3B 4B
CTRA Dividend Payout.CTRA Dividend Payout, showing the Payout Ratio.CTRA Dividend Payout.PayoutRetained Earnings

More info and screens

Find the best dividend stocksShow peers with best dividend

COTERRA ENERGY INC

NYSE:CTRA (2/13/2026, 8:04:00 PM)

After market: 31.38 +0.01 (+0.03%)

31.37

+0.59 (+1.92%)

Chartmill FA Rating
GICS SectorEnergy
GICS IndustryGroupEnergy
GICS IndustryOil, Gas & Consumable Fuels
Earnings (Last)11-03
Earnings (Next)02-26
Inst Owners95.23%
Inst Owner Change0%
Ins Owners0.85%
Ins Owner Change-3.38%
Market Cap23.88B
Revenue(TTM)7.08B
Net Income(TTM)1.65B
Analysts82.42
Price Target33.12 (5.58%)
Short Float %4.13%
Short Ratio3.54
Dividend
Industry RankSector Rank
Dividend Yield 2.9%
Yearly Dividend0.84
Dividend Growth(5Y)18.85%
DP40.64%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-2.46%
Min EPS beat(2)-9.02%
Max EPS beat(2)4.09%
EPS beat(4)2
Avg EPS beat(4)1.17%
Min EPS beat(4)-9.02%
Max EPS beat(4)10.97%
EPS beat(8)3
Avg EPS beat(8)0.34%
EPS beat(12)7
Avg EPS beat(12)4.24%
EPS beat(16)10
Avg EPS beat(16)3.69%
Revenue beat(2)1
Avg Revenue beat(2)6.12%
Min Revenue beat(2)-0.82%
Max Revenue beat(2)13.06%
Revenue beat(4)2
Avg Revenue beat(4)1.97%
Min Revenue beat(4)-5.32%
Max Revenue beat(4)13.06%
Revenue beat(8)5
Avg Revenue beat(8)0.94%
Revenue beat(12)7
Avg Revenue beat(12)0.87%
Revenue beat(16)10
Avg Revenue beat(16)2.64%
PT rev (1m)0.95%
PT rev (3m)0.08%
EPS NQ rev (1m)-10.82%
EPS NQ rev (3m)-16.65%
EPS NY rev (1m)-2.28%
EPS NY rev (3m)-8.51%
Revenue NQ rev (1m)-4.16%
Revenue NQ rev (3m)-4.16%
Revenue NY rev (1m)-0.88%
Revenue NY rev (3m)-1.49%
Valuation
Industry RankSector Rank
PE 14.39
Fwd PE 14.08
P/S 3.37
P/FCF 16.49
P/OCF 6.5
P/B 1.62
P/tB 1.62
EV/EBITDA 6.21
EPS(TTM)2.18
EY6.95%
EPS(NY)2.23
Fwd EY7.1%
FCF(TTM)1.9
FCFY6.06%
OCF(TTM)4.83
OCFY15.39%
SpS9.3
BVpS19.34
TBVpS19.34
PEG (NY)0.46
PEG (5Y)121.16
Graham Number30.8
Profitability
Industry RankSector Rank
ROA 6.86%
ROE 11.18%
ROCE 9.85%
ROIC 7.86%
ROICexc 7.9%
ROICexgc 7.9%
OM 31.31%
PM (TTM) 23.25%
GM 82.81%
FCFM 20.45%
ROA(3y)11.08%
ROA(5y)8.7%
ROE(3y)17.66%
ROE(5y)14.37%
ROIC(3y)12.27%
ROIC(5y)9.93%
ROICexc(3y)12.9%
ROICexc(5y)10.44%
ROICexgc(3y)12.9%
ROICexgc(5y)10.44%
ROCE(3y)15.36%
ROCE(5y)12.44%
ROICexgc growth 3Y-7.45%
ROICexgc growth 5Y-19.44%
ROICexc growth 3Y-7.45%
ROICexc growth 5Y-19.44%
OM growth 3Y-19.39%
OM growth 5Y-9.76%
PM growth 3Y-15.14%
PM growth 5Y-9.04%
GM growth 3Y1.7%
GM growth 5Y3.22%
F-Score7
Asset Turnover0.29
Health
Industry RankSector Rank
Debt/Equity 0.25
Debt/FCF 2.71
Debt/EBITDA 0.84
Cap/Depr 102.44%
Cap/Sales 31.48%
Interest Coverage 250
Cash Conversion 83.7%
Profit Quality 87.97%
Current Ratio 1.02
Quick Ratio 0.98
Altman-Z 2.51
F-Score7
WACC8.05%
ROIC/WACC0.98
Cap/Depr(3y)110.23%
Cap/Depr(5y)116.61%
Cap/Sales(3y)28.94%
Cap/Sales(5y)29.44%
Profit Quality(3y)93.33%
Profit Quality(5y)92.4%
High Growth Momentum
Growth
EPS 1Y (TTM)26.74%
EPS 3Y-5.3%
EPS 5Y0.12%
EPS Q2Q%28.12%
EPS Next Y31.29%
EPS Next 2Y14.82%
EPS Next 3Y18.81%
EPS Next 5Y15.83%
Revenue 1Y (TTM)25.13%
Revenue growth 3Y16.53%
Revenue growth 5Y21.44%
Sales Q2Q%33.7%
Revenue Next Year37.46%
Revenue Next 2Y18.81%
Revenue Next 3Y14.98%
Revenue Next 5Y11.96%
EBIT growth 1Y35.27%
EBIT growth 3Y-6.06%
EBIT growth 5Y9.59%
EBIT Next Year218.31%
EBIT Next 3Y54.08%
EBIT Next 5Y33.65%
FCF growth 1Y-35.59%
FCF growth 3Y2.93%
FCF growth 5Y9.27%
OCF growth 1Y-16.09%
OCF growth 3Y18.8%
OCF growth 5Y14.09%

COTERRA ENERGY INC / CTRA FAQ

What is the fundamental rating for CTRA stock?

ChartMill assigns a fundamental rating of 6 / 10 to CTRA.


Can you provide the valuation status for COTERRA ENERGY INC?

ChartMill assigns a valuation rating of 6 / 10 to COTERRA ENERGY INC (CTRA). This can be considered as Fairly Valued.


How profitable is COTERRA ENERGY INC (CTRA) stock?

COTERRA ENERGY INC (CTRA) has a profitability rating of 7 / 10.


How financially healthy is COTERRA ENERGY INC?

The financial health rating of COTERRA ENERGY INC (CTRA) is 5 / 10.


Can you provide the expected EPS growth for CTRA stock?

The Earnings per Share (EPS) of COTERRA ENERGY INC (CTRA) is expected to grow by 31.29% in the next year.